Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (131-140 of 384) with videos related to

Pageof 39
Sort By:
Haemostasis|January 1, 1991
Recombinant hirudin--initial observations in reconstructive microsurgeryK Narayanan, J M Walenga, M D Liang, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Lupus anticoagulant assaysH Messmore, N Fabbrini, D Hoppensteadt, et al.
Thrombosis Research|March 1, 1994
Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systemsB Kaiser, D Callas, D Hoppensteadt, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Molecular markers of hemostatic activation and inflammation following major injury: effect of therapy with IFN-gammaD J Dries, J M Walenga, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Performance characteristics of a simple radioimmunoassay for fibrinopeptide AJ M Walenga, D Hoppensteadt, R M Emanuele, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Pharmacokinetics of low molecular weight heparins in animal modelsJ Fareed, K Fu, L H Yang, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Development and validation of two enzyme-linked immunosorbent assay (ELISA) methods for recombinant hirudinL Iyer, M Adam, J Amiral, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Heparin-induced thrombocytopenia: clinical considerations of alternative anticoagulation with various glycosaminoglycans and thrombin inhibitorsS Haas, J M Walenga, W P Jeske, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
Pharmacology of argatrobanW Jeske, J M Walenga, B E Lewis, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Thrombin anion-binding exosite interactions with heparin and various polyanionsJ W Fenton, J I Witting, C Pouliott, et al.
Pageof 39

Showing results (131-140 of 384) with videos related to

Sort By:
Pageof 39
Haemostasis|January 1, 1991
Recombinant hirudin--initial observations in reconstructive microsurgeryK Narayanan, J M Walenga, M D Liang, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Lupus anticoagulant assaysH Messmore, N Fabbrini, D Hoppensteadt, et al.
Thrombosis Research|March 1, 1994
Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systemsB Kaiser, D Callas, D Hoppensteadt, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Molecular markers of hemostatic activation and inflammation following major injury: effect of therapy with IFN-gammaD J Dries, J M Walenga, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Performance characteristics of a simple radioimmunoassay for fibrinopeptide AJ M Walenga, D Hoppensteadt, R M Emanuele, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Pharmacokinetics of low molecular weight heparins in animal modelsJ Fareed, K Fu, L H Yang, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Development and validation of two enzyme-linked immunosorbent assay (ELISA) methods for recombinant hirudinL Iyer, M Adam, J Amiral, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Heparin-induced thrombocytopenia: clinical considerations of alternative anticoagulation with various glycosaminoglycans and thrombin inhibitorsS Haas, J M Walenga, W P Jeske, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
Pharmacology of argatrobanW Jeske, J M Walenga, B E Lewis, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Thrombin anion-binding exosite interactions with heparin and various polyanionsJ W Fenton, J I Witting, C Pouliott, et al.
Pageof 39